$AMWD

Rodriguez David A sold (to issuer) 10,522 shares of AMWD

Rodriguez David A sold (to issuer) 10,522 shares of AMERICAN WOODMARK CORP (AMWD) on 2026-05-28.

Original reporting
SEC EDGAR · Rodriguez David A
Published May 29, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 29, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMWD
Neutral
medium confidence
Mentioned
$AMWD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWDNeutralLow
01

Why it matters

The disclosure updates insider ownership (director ends with 0 shares) but does not, by itself, indicate a change in company fundamentals or near-term catalysts.

02

Market read

Traders may note the insider ownership change, but the lack of disclosed price/value and absence of a stated company event keeps the trading signal weak.

03

What to watch

The transaction is coded as “sale to issuer,” which often occurs in structured buyback/issuer programs; without disclosed price/value, the economic signal is hard to quantify.

Relevance 4/10Novelty 3/10Timing: Filed after-hours on 2026-05-29; transaction dated 2026-05-28

Background

This is an SEC Form 4 insider transaction disclosure for American Woodmark (AMWD). The director sold shares to the issuer; price and total value are not disclosed.

Company-level read

Ticker impact

$AMWDNeutralMedium confidence
Context

AMWD director Rodriguez sold 10,522 shares to the issuer (buyback participation), leaving 0 shares after the transaction.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless followed by additional insider activity or company-specific news.

Evidence & confidence

Insider Form 4s are typically routine disclosures; the article provides no disclosed price/value and explicitly notes no pre-arranged 10b5-1 plan, but does not provide a new company event.

Market effects

None—single-company insider transaction with no sector-wide read-across provided.

None indicated.

None indicated.

Counterpoint

Because the filing states no 10b5-1 plan, the sale could be interpreted as more discretionary than routine, potentially increasing sensitivity to subsequent insider disclosures.

Key entities

  • AMERICAN WOODMARK CORP

    Subject of the Form 4 insider transaction; director sold 10,522 shares to the issuer.

  • Rodriguez David A

    Director who sold shares; holdings after transaction reported as 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FDXFMedAI 8/10

FedEx Freight Holding Company Set to Join S&P 500; EPAM Systems and Dave to Join S&P SmallCap 600

S&P Dow Jones Indices said FedEx Freight Holding Company (FDXF) will replace EPAM Systems (EPAM) in the S&P 500 before the June 2 open, after FedEx Corp.’s (FDX) planned spin-off of FedExFreight Holding expected to complete June 1. EPAM will replace Shutterstock (SSTK) in the S&P SmallCap 600. Also, Dave (DAVE) will replace American Woodmark (AMWD) in the SmallCap 600 before June 1 open, after MasterBrand’s planned AMWD acquisition expected to close May 29.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).